文献速递胸部肿瘤

美国患者对Lung-RADS推荐肺癌CT筛查间期的依从性:系统综述与荟萃分析

Patient Adherence to Lung CT Screening Reporting & Data System-Recommended Screening Intervals in the United States: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Thorac Oncol · 2021-10-06

该系统综述与荟萃分析检索多个数据库及会议档案,纳入24项研究(21项可合并),评估美国肺癌CT筛查项目中对Lung-RADS推荐筛查间期的患者依从性。合并依从率在定义依从(如15个月内完成年度筛查)为57%(95%CI 46%-69%),任意时间依从为65%(95%CI 55%-75%),异质性高,且Lung-RADS 3-4类患者依从率显著高于1-2类。结论认为依从性欠佳,尤其1-2类患者。

要点

  • 美国LCS项目中对Lung-RADS推荐间期的合并依从率仅57%(定义依从)和65%(任意时间依从)。
  • Lung-RADS 3-4类患者的依从率显著高于1-2类患者(p<0.05)。
  • 研究间异质性极高(I²=99%和98%),需针对性干预改善依从性。

核心结论

  • 美国肺癌CT筛查项目中对Lung-RADS推荐筛查间期的患者依从性不理想,尤其在Lung-RADS 1-2类患者中更低。

主要发现

  • 定义依从(如15个月内完成年度筛查)的合并依从率为57%(95%CI 46%-69%),涉及6689例患者。
  • 任意时间依从的合并依从率为65%(95%CI 55%-75%),涉及5085例患者。
  • 研究间异质性高:定义依从I²=99%,任意时间依从I²=98%。
  • 依从率与Lung-RADS评分相关,Lung-RADS 3-4类显著高于1-2类(p<0.05)。

关键数值与推荐

  • 定义依从示例:年度筛查在15个月内完成。
  • 合并依从率:定义依从57%(95%CI 46%-69%),任意时间依从65%(95%CI 55%-75%)。

临床怎么用

  • 临床肺癌筛查项目应关注患者对Lung-RADS推荐间期的依从性,尤其对Lung-RADS 1-2类患者加强随访提醒。
  • 未来可识别依从障碍并实施针对性干预以提高依从率。

局限性

  • 研究间异质性极高(I²达99%和98%),可能影响合并结果的解释。
  • 依从率定义不一致(定义依从与任意时间依从)导致比较受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lung cancer screening (LCS) is effective in reducing mortality, particularly when patients adhere to follow-up recommendations standardized by the Lung CT Screening Reporting & Data System (Lung-RADS). Nevertheless, patient adherence to recommended intervals varies, potentially diminishing benefit from screening. We conducted a systematic review and meta-analysis of patient adherence to Lung-RADS-recommended screening intervals. We systematically searched MEDLINE, EMBASE, Web of Science, the Cochrane Central Register of Controlled Trials, and major radiology and oncology conference archives between April 28, 2014, and December 17, 2020. Eligible studies mentioned patient adherence to the recommendations of Lung-RADS. The review protocol was registered with PROSPERO (CRD42020189326). We identified 24 eligible studies for qualitative summary, of which 21 were suitable for meta-analysis. The pooled adherence rate was 57% (95% confidence interval: 46%-69%) for defined adherence (e.g., an annual incidence screen was performed within 15 mo) among 6689 patients and 65% (95% confidence interval: 55%-75%) for anytime adherence among 5085 patients. Large heterogeneity in adherence rates between studies was observed (I2 = 99% for defined adherence, I2 = 98% for anytime adherence). Heterogeneous adherence rates were associated with Lung-RADS scores, with significantly higher adherence rates among Lung-RADS 3 to 4 than Lung-RADS 1 to 2 (p < 0.05). Patient adherence to Lung-RADS-recommended screening intervals is suboptimal across clinical LCS programs in the United States, especially among patients with results of Lung-RADS categories 1 to 2. To improve adherence rates, future research may focus on implementing tailored interventions after identifying barriers to LCS. We also propose a minimum standardized set of data elements for future pooled analyses of LCS adherence on the basis of our findings.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Lin Y, Fu M, Ding R, et al. Patient Adherence to Lung CT Screening Reporting & Data System-Recommended Screening Intervals in the United States: A Systematic Review and Meta-Analysis. J Thorac Oncol. 2021. PMID: 34624528. doi:10.1016/j.jtho.2021.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。